These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3016496)

  • 1. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade.
    Neve KA; Molinoff PB
    Mol Pharmacol; 1986 Aug; 30(2):104-11. PubMed ID: 3016496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta adrenergic receptor repopulation of C6 glioma cells after irreversible blockade and down regulation.
    Homburger V; Pantaloni C; Lucas M; Gozlan H; Bockaert J
    J Cell Physiol; 1984 Dec; 121(3):589-97. PubMed ID: 6094600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach to determine rates of receptor appearance and disappearance in vivo. Application to agonist-mediated down-regulation of rat renal cortical beta 1- and beta 2-adrenergic receptors.
    Snavely MD; Ziegler MG; Insel PA
    Mol Pharmacol; 1985 Jan; 27(1):19-26. PubMed ID: 2981399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.
    Zaremba TG; Fishman PH
    Mol Pharmacol; 1984 Sep; 26(2):206-13. PubMed ID: 6207420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist-mediated regulation of alpha 1- and beta 2-adrenergic receptor metabolism in a muscle cell line, BC3H-1.
    Hughes RJ; Insel PA
    Mol Pharmacol; 1986 Jun; 29(6):521-30. PubMed ID: 3012317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. I. Receptor metabolism after irreversible blockade of receptors and in cells traversing the cell division cycle.
    Mahan LC; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):7-15. PubMed ID: 2868411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a density shift method to assess beta-adrenergic receptor synthesis during recovery from catecholamine-induced down-regulation in human astrocytoma cells.
    Waldo GL; Doss RC; Perkins JP; Harden TK
    Mol Pharmacol; 1984 Nov; 26(3):424-9. PubMed ID: 6092895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists.
    Neve KA; Barrett DA; Molinoff PB
    J Pharmacol Exp Ther; 1985 Dec; 235(3):657-64. PubMed ID: 2867205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of agonists and antagonists with beta-adrenergic receptors on intact L6 muscle cells.
    Pittman RN; Molinoff PB
    J Cyclic Nucleotide Res; 1980; 6(6):421-35. PubMed ID: 6260844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a bromoacetylated derivative of pindolol as a high affinity, irreversible beta adrenergic antagonist in cultured cells.
    Jasper JR; Motulsky HJ; Insel PA
    J Pharmacol Exp Ther; 1988 Mar; 244(3):820-4. PubMed ID: 2908047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tunicamycin on the expression of beta-adrenergic receptors in human astrocytoma cells during growth and recovery from agonist-induced down-regulation.
    Doss RC; Kramarcy NR; Harden TK; Perkins JP
    Mol Pharmacol; 1985 May; 27(5):507-16. PubMed ID: 2985949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors.
    Neve KA; McGonigle P; Molinoff PB
    J Pharmacol Exp Ther; 1986 Jul; 238(1):46-53. PubMed ID: 3014123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid regulation of beta-adrenergic receptors in 3T3-L1 preadipocytes.
    Nakada MT; Stadel JM; Poksay KS; Crooke ST
    Mol Pharmacol; 1987 Apr; 31(4):377-84. PubMed ID: 3033466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoproterenol-initiated beta-adrenergic receptor diacytosis in cultured cells.
    Kurz JB; Perkins JP
    Mol Pharmacol; 1992 Feb; 41(2):375-81. PubMed ID: 1347147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of full and partial agonists with beta-adrenergic receptors on intact L6 muscle cells.
    Pittman RN; Molinoff PB
    Mol Pharmacol; 1983 Nov; 24(3):398-408. PubMed ID: 6138704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro study of alpha 2-adrenoceptor turnover and metabolism using the adenocarcinoma cell line HT29.
    Paris H; Taouis M; Galitzky J
    Mol Pharmacol; 1987 Nov; 32(5):646-54. PubMed ID: 2891026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitization and resensitization of beta-adrenergic receptors in a smooth muscle cell line.
    Scarpace PJ; Baresi LA; Sanford DA; Abrass IB
    Mol Pharmacol; 1985 Dec; 28(6):495-501. PubMed ID: 2867463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of beta-adrenergic receptors throughout the replicative life span of IMR-90 cells.
    Scarpace PJ
    J Cell Physiol; 1987 Jan; 130(1):163-7. PubMed ID: 3027107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta 2-adrenoceptor agonist-induced down-regulation after short-term exposure.
    Hardin AO; Lima JJ
    J Recept Signal Transduct Res; 1999 Sep; 19(5):835-52. PubMed ID: 10349597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of gonadotropin and beta-adrenergic receptors by hormones and cyclic AMP.
    Fishman PH; Rebois RV; Zaremba T
    J Cell Biochem; 1985; 27(3):231-9. PubMed ID: 2985637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.